HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ganglioneuroblastoma

A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.
Also Known As:
Ganglioneuroblastomas
Networked: 222 relevant articles (0 outcomes, 12 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neuroblastoma
2. Neoplasms (Cancer)
3. Pheochromocytoma
4. Vipoma (WDHA)
5. Ganglioneuroma

Experts

1. Shimada, Hiroyuki: 4 articles (07/2020 - 10/2004)
2. Maris, John M: 4 articles (01/2017 - 07/2008)
3. Matthay, Katherine K: 3 articles (01/2022 - 10/2004)
4. Wu, Yeming: 3 articles (10/2018 - 01/2013)
5. London, Wendy B: 3 articles (01/2017 - 10/2009)
6. Naranjo, Arlene: 3 articles (01/2017 - 10/2009)
7. Seeger, Robert C: 3 articles (03/2013 - 10/2004)
8. Defachelles, Anne-Sophie: 2 articles (12/2021 - 05/2006)
9. Akatani, Norihito: 2 articles (11/2020 - 09/2020)
10. Araki, Raita: 2 articles (11/2020 - 09/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ganglioneuroblastoma:
1. Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
2. Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
3. Cyclin D1IBA
4. CatecholaminesIBA
5. Peptides (Polypeptides)IBA
6. Adrenocorticotropic Hormone (ACTH)FDA Link
7. Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
8. Substance PIBA
9. RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10. Corticotropin-Releasing HormoneIBA

Therapies and Procedures

1. Immunotherapy
2. Drug Therapy (Chemotherapy)
3. Therapeutics
4. Radiotherapy
5. Adrenalectomy